Objave podjetij · 13. 11. 20261 min read

Leqembi® Pen subcutaneous treatment launched in Japan

Lokalni samodejni prevod · Izvirni jezik vira

Illustration generated by Business News; it is not a source photograph.

Summary

STOCKHOLM, Nov. 13, 2026 — BioArctic AB's (publ) (NASDAQ Stockholm: BIOA B) partner Eisai today announced that Leqembi Pen, the subcutaneous formulation of lecanemab, has been launched in Japan for the…

Izvirni jezik vira: PR Newswire UK — News ReleasesOdprite izvirno obvestilo →

Leqembi® Pen subcutaneous treatment launched in Japan

Investitorji Webull Corporation (BULL): Ročni rok za podajanje prijav 7. decembra 2026, v sklopu sodnega postopka zaradi obdavčevalnega pravosodja - kontaktirajte Kessler Topaz Meltzer & Check, LLP